KHB Unveils Polaris V150 at MEDICA 2025
Kehua Bio-engineering Co., Ltd. (KHB), a renowned global supplier of in-vitro diagnostic (IVD) solutions, presented its innovative Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer at the prestigious MEDICA 2025 exhibition. This state-of-the-art analyzer is designed to enhance lab efficiency and diagnostic accuracy while maintaining a compact footprint, making it ideal for small to medium-sized laboratories as well as emergency settings in larger institutions.
Compact Design Meets High Performance
Despite its minimal space requirement of just 0.36 square meters, the Polaris V150 boasts impressive capabilities, delivering up to 150 tests per hour. This level of performance enables laboratories to optimize workflow, even in confined environments. The system includes automatic features such as continuous loading for samples and reagents alongside a STAT function that prioritizes urgent tests, thus facilitating swift clinical decisions.
Advanced Technology for Superior Accuracy
The Polaris V150 is powered by advanced ALP–AMPPD technology, providing outstanding accuracy and precision (CV < 3%) across all assays. Additionally, it employs an all-in-one reagent kit design, significantly simplifying reagent management and standardizing operations for end-users. This innovative approach allows for the incorporation of calibrators with QR codes, further enhancing usability in laboratory settings.
Comprehensive Assay Menu
With over 60 assays available across ten major disease panels, the Polaris V150 addresses a wide spectrum of diagnostic needs. The analytes encompass thyroid function, sex hormones, tumor markers, infectious diseases, and more, ensuring versatility in routine diagnostics and emergency situations alike.
Intelligent Design and User-Centric Features
The user experience is paramount with the Polaris V150. Its intuitive touchscreen interface allows for seamless navigation and minimal training time for new users. The analyzer supports real-time monitoring of reagents and consumables, ensuring laboratories are always prepared for testing demands. Furthermore, it includes advanced safety functions like liquid-level detection and clot recognition, enhancing reliability during tests.
Maintaining Reagent Stability and Continuous Operation
To ensure optimal performance and reagent integrity, the Polaris V150 features onboard refrigeration at 2–8°C for up to 12 reagent positions. This capability safeguards the stability of reagents for prolonged periods, while functionalities such as remote monitoring and automated maintenance minimize downtime and support uninterrupted laboratory operations.
Highlight of MEDICA 2025
During MEDICA 2025, the Polaris V150 attracted significant interest at the KHB booth, demonstrating a strong demand for reliable, compact immunoassay solutions. Live demonstrations showcasing its capabilities were well-received by attendees, marking it as a pivotal addition to modern laboratory diagnostics. KHB's product manager expressed enthusiasm about the positive reception, highlighting the need for efficient solutions in both routine and emergency testing scenarios.
About KHB
Shanghai Kehua Bio-engineering Co., Ltd., known as KHB, has been at the forefront of the IVD sector since its founding in 1981. With a broad range of diagnostic products, KHB's commitment to innovation is reflected in their diverse offerings in immunoassay, biochemical diagnoses, molecular diagnostics, and point-of-care testing. The company has been listed on the Shenzhen Stock Exchange since 2004 and continues to develop cutting-edge solutions that enhance laboratory efficiencies worldwide.
For more information about KHB and its innovative products, visit
KHB's official website or follow them on
LinkedIn.